Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Horti

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Social Science & Medicine (1982)|January 1, 1986
Concern about cancer in women undergoing elective gynaecological surgeryA Steptoe, J Horti, S Stanton
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 17, 2007
Prostate cancer screeningP Tenke, J Horti, P Balint, et al.
Orvosi Hetilap|December 18, 1994
[Review of drugs used in the neutropenic period following cytostatic therapy and comparative study of doxycycline and ofloxacin in the treatment of patients with testicular cancer]M Baki, I Bodrogi, J Horti, et al.
Neoplasma|August 31, 1999
Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinomaI N Arah, S C Dixon, J Horti, et al.
Oncology Reports|June 19, 1998
A phase II study of bromocriptine in patients with androgen-independent prostate cancerJ Horti, W D Figg, B Weinberger, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2008
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancerJ Horti, E Juhasz, Z Monostori, et al.
International Urology and Nephrology|January 1, 1995
Results of salvage retroperitoneal lymphadenectomy (RLA) in the treatment of patients with nonseminomatous germ cell tumours remaining marker positive after inductive chemotherapyL Kisbenedek, I Bodrogi, P Szeldeli, et al.
British Journal of Cancer|April 3, 1999
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitorJ Horti, S C Dixon, C J Logothetis, et al.
Neoplasma|January 1, 1990
Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumorsI Bodrogi, M Baki, J Horti, et al.
Acta Medica Hungarica|January 1, 1994
Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumoursI Bodrogi, M Baki, J Horti, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Social Science & Medicine (1982)|January 1, 1986
Concern about cancer in women undergoing elective gynaecological surgeryA Steptoe, J Horti, S Stanton
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 17, 2007
Prostate cancer screeningP Tenke, J Horti, P Balint, et al.
Orvosi Hetilap|December 18, 1994
[Review of drugs used in the neutropenic period following cytostatic therapy and comparative study of doxycycline and ofloxacin in the treatment of patients with testicular cancer]M Baki, I Bodrogi, J Horti, et al.
Neoplasma|August 31, 1999
Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinomaI N Arah, S C Dixon, J Horti, et al.
Oncology Reports|June 19, 1998
A phase II study of bromocriptine in patients with androgen-independent prostate cancerJ Horti, W D Figg, B Weinberger, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2008
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative, for the treatment of patients with non-small cell lung cancerJ Horti, E Juhasz, Z Monostori, et al.
International Urology and Nephrology|January 1, 1995
Results of salvage retroperitoneal lymphadenectomy (RLA) in the treatment of patients with nonseminomatous germ cell tumours remaining marker positive after inductive chemotherapyL Kisbenedek, I Bodrogi, P Szeldeli, et al.
British Journal of Cancer|April 3, 1999
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitorJ Horti, S C Dixon, C J Logothetis, et al.
Neoplasma|January 1, 1990
Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumorsI Bodrogi, M Baki, J Horti, et al.
Acta Medica Hungarica|January 1, 1994
Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumoursI Bodrogi, M Baki, J Horti, et al.
Pageof 2